BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30664843)

  • 1. Prosthetic Replacement of the Ocular Surface Ecosystem Treatment for Ocular Surface Disease in Pediatric Patients With Stevens-Johnson Syndrome.
    Wang Y; Rao R; Jacobs DS; Saeed HN
    Am J Ophthalmol; 2019 May; 201():1-8. PubMed ID: 30664843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Papakostas TD; Le HG; Chodosh J; Jacobs DS
    Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome.
    Heur M; Bach D; Theophanous C; Chiu GB
    Am J Ophthalmol; 2014 Jul; 158(1):49-54. PubMed ID: 24699156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease.
    Basu S; Shanbhag SS; Gokani A; Kedar R; Bahuguna C; Sangwan VS
    Am J Ophthalmol; 2018 May; 189():17-28. PubMed ID: 29421293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lid-Related Keratopathy in Stevens-Johnson Syndrome: Natural Course and Impact of Therapeutic Interventions in Children and Adults.
    Shanbhag SS; Shah S; Singh M; Bahuguna C; Donthineni PR; Basu S
    Am J Ophthalmol; 2020 Nov; 219():357-365. PubMed ID: 32681905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson Syndrome and Corneal Ectasia: Management and a Case for Association.
    Saeed HN; Kohanim S; Le HG; Chodosh J; Jacobs DS
    Am J Ophthalmol; 2016 Sep; 169():276-281. PubMed ID: 27386788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Sotozono C; Yamauchi N; Maeda S; Kinoshita S
    Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease.
    Parra AS; Roth BM; Nguyen TM; Wang L; Pflugfelder SC; Al-Mohtaseb Z
    Ocul Surf; 2018 Apr; 16(2):254-258. PubMed ID: 29425812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.
    Kim KH; Park SW; Kim MK; Wee WR
    Korean J Ophthalmol; 2013 Oct; 27(5):331-40. PubMed ID: 24082770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.
    Yin J; Jacobs DS
    Ocul Surf; 2019 Jan; 17(1):134-141. PubMed ID: 30468876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
    Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
    Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of corneoscleral contact lenses on refractory ocular surface diseases.
    Lee SM; Kim YJ; Choi SH; Oh JY; Kim MK
    Cont Lens Anterior Eye; 2019 Aug; 42(4):399-405. PubMed ID: 30389416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy.
    Chahal JS; Heur M; Chiu GB
    Eye Contact Lens; 2017 Jul; 43(4):240-244. PubMed ID: 27171131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
    Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.
    Iyer G; Srinivasan B; Agarwal S; Kamala Muralidharan S; Arumugam S
    Graefes Arch Clin Exp Ophthalmol; 2014 Mar; 252(3):457-67. PubMed ID: 24469247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
    Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
    Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleral contact lenses in the management of pellucid marginal degeneration.
    Rathi VM; Dumpati S; Mandathara PS; Taneja MM; Sangwan VS
    Cont Lens Anterior Eye; 2016 Jun; 39(3):217-20. PubMed ID: 26669275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Shanbhag SS; Rashad R; Chodosh J; Saeed HN
    Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Itoi M; Ueta M; Ogino K; Sumi E; Imai K; Teramukai S; Kinoshita S; Sotozono C
    Cont Lens Anterior Eye; 2020 Dec; 43(6):535-542. PubMed ID: 32513522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.
    DeLoss KS; Fatteh NH; Hood CT
    Am J Ophthalmol; 2014 Nov; 158(5):974-82. PubMed ID: 25058902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.